Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Goodwill (2016 - 2023)

Angiodynamics (ANGO) has disclosed Goodwill for 13 consecutive years, with $159.2 million as the latest value for Q4 2023.

  • For the quarter ending Q4 2023, Goodwill fell 20.69% year-over-year to $159.2 million, compared with a TTM value of $159.2 million through Nov 2023, down 20.69%, and an annual FY2022 reading of $201.1 million, changed 0.13% over the prior year.
  • Goodwill was $159.2 million for Q4 2023 at Angiodynamics, roughly flat from $159.0 million in the prior quarter.
  • Across five years, Goodwill topped out at $347.7 million in Q3 2019 and bottomed at $12.4 million in Q4 2019.
  • Average Goodwill over 5 years is $189.6 million, with a median of $201.0 million recorded in 2022.
  • The sharpest move saw Goodwill surged 1518.26% in 2020, then decreased 20.9% in 2023.
  • Year by year, Goodwill stood at $12.4 million in 2019, then soared by 1518.26% to $201.1 million in 2020, then rose by 0.29% to $201.7 million in 2021, then dropped by 0.47% to $200.8 million in 2022, then dropped by 20.69% to $159.2 million in 2023.
  • Business Quant data shows Goodwill for ANGO at $159.2 million in Q4 2023, $159.0 million in Q3 2023, and $200.8 million in Q4 2022.